| http://www.w3.org/ns/prov#value | - A team of Mayo Clinic scientists led by Dr. Vanda Lennon recently reported the discovery of a protein targeted by an antibody that distinguishes neuromyelitis optica (NMO, also known as Devic's disease) from more common forms of multiple sclerosis (MS) that are generally less severe. (See publications below.) The antibody is proving to be a valuable blood test for establishing the diagnosis of NMO
|
